» Articles » PMID: 35084562

Aminophylline at Clinically Relevant Concentrations Affects Inward Rectifier Potassium Current in a Dual Way

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2022 Jan 27
PMID 35084562
Authors
Affiliations
Soon will be listed here.
Abstract

Bronchodilator aminophylline may induce atrial or less often ventricular arrhythmias. The mechanism of this proarrhythmic side effect has not been fully explained. Modifications of inward rectifier potassium (Kir) currents including I are known to play an important role in arrhythmogenesis; however, no data on the aminophylline effect on these currents have been published. Hence, we tested the effect of aminophylline (3-100 µM) on I in enzymatically isolated rat ventricular myocytes using the whole-cell patch-clamp technique. A dual steady-state effect of aminophylline was observed; either inhibition or activation was apparent in individual cells during the application of aminophylline at a given concentration. The smaller the magnitude of the control I, the more likely the activation of the current by aminophylline and vice versa. The effect was reversible; the relative changes at -50 and -110 mV did not differ. Using I channel population model, the dual effect was explained by the interaction of aminophylline with two different channel populations, the first one being inhibited and the second one being activated. Considering various fractions of these two channel populations in individual cells, varying effects observed in the measured cells could be simulated. We propose that the dual aminophylline effect may be related to the direct and indirect effect of the drug on various Kir2.x subunits forming the homo- and heterotetrameric I channels in a single cell. The observed I changes induced by clinically relevant concentrations of aminophylline might contribute to arrhythmogenesis related to the use of this bronchodilator in clinical medicine.

Citing Articles

Salbutamol attenuates arrhythmogenic effect of aminophylline in a hPSC-derived cardiac model.

Kabanov D, Vrana Klimovic S, Beckerova D, Molcan M, Scurek M, Brat K Sci Rep. 2024; 14(1):27399.

PMID: 39521810 PMC: 11550379. DOI: 10.1038/s41598-024-76846-4.


Could the serum glucose/potassium ratio offer an early reliable predictor of life-threatening events in acute methylxanthine intoxication?.

Sharif A, Kasemy Z, Mabrouk H, Shoeib O, Fayed M Toxicol Res (Camb). 2023; 12(2):310-320.

PMID: 37125326 PMC: 10141764. DOI: 10.1093/toxres/tfad023.


Trends in research on sick sinus syndrome: A bibliometric analysis from 2000 to 2022.

Zhang X, Zhao Y, Zhou Y, Lv J, Peng J, Zhu H Front Cardiovasc Med. 2022; 9:991503.

PMID: 36440047 PMC: 9681915. DOI: 10.3389/fcvm.2022.991503.

References
1.
Mahemuti G, Zhang H, Li J, Tieliwaerdi N, Ren L . Efficacy and side effects of intravenous theophylline in acute asthma: a systematic review and meta-analysis. Drug Des Devel Ther. 2018; 12:99-120. PMC: 5768195. DOI: 10.2147/DDDT.S156509. View

2.
Saint G, Semple M, Sinha I, Hawcutt D . Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children. Paediatr Drugs. 2018; 20(3):209-214. PMC: 5954054. DOI: 10.1007/s40272-017-0281-x. View

3.
Cooney L, Sinha I, Hawcutt D . Aminophylline Dosage In Asthma Exacerbations in Children: A Systematic Review. PLoS One. 2016; 11(8):e0159965. PMC: 4970720. DOI: 10.1371/journal.pone.0159965. View

4.
Neame M, Aragon O, Fernandes R, Sinha I . Salbutamol or aminophylline for acute severe asthma: how to choose which one, when and why?. Arch Dis Child Educ Pract Ed. 2015; 100(4):215-22. DOI: 10.1136/archdischild-2014-306186. View

5.
Ye C, Miao C, Yu L, Dong Z, Zhang J, Mao Y . Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit. Pediatr Neonatol. 2018; 60(1):43-49. DOI: 10.1016/j.pedneo.2018.03.008. View